Cargando…
Drug‐induced cholestasis
Cholestatic drug‐induced liver injury (DILI) can be a diagnostic challenge due to a large differential diagnosis, variability in clinical presentation, and lack of serologic biomarkers associated with this condition. The clinical presentation of drug‐induced cholestasis includes bland cholestasis, c...
Autores principales: | Sundaram, Vinay, Björnsson, Einar S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678916/ https://www.ncbi.nlm.nih.gov/pubmed/29404489 http://dx.doi.org/10.1002/hep4.1088 |
Ejemplares similares
-
Biologic and Checkpoint Inhibitor‐Induced Liver Injury: A Systematic Literature Review
por: Shah, Parth, et al.
Publicado: (2020) -
Severe cholestatic hepatitis due to large vessel vasculitis: report of two cases
por: Xu, Jason, et al.
Publicado: (2018) -
Molecular and Clinical Links between Drug-Induced Cholestasis and Familial Intrahepatic Cholestasis
por: Vitale, Giovanni, et al.
Publicado: (2023) -
Hepatotoxicity by Drugs: The Most Common Implicated Agents
por: Björnsson, Einar S.
Publicado: (2016) -
Now You See It, Now You Do Not: A Case of Infliximab-Induced Vanishing Bile Duct Syndrome
por: Shah, Parth, et al.
Publicado: (2019)